Similarly, PTEN was positively correlated with C1GALT1 expression in prostate cancer as well as in pancreatic, colon, rectal, cervical/endocervical, bladder, kidney‐clear cell, head and neck, thyroid, breast, liver cancers, and melanoma. Here, PTEN is linked to prostate carcinoma.